Pharma Industry News

ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk

Learn more -> https://www.empr.com/home/news/ada-tirzepatide-improves-kidney-outcomes-in-t2dm-with-increased-cv-risk/

ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk Fewer renal complications seen with tirzepatide versus insulin glargine in adults with T2D and increased cardiovascular risk

Using New Guidelines Would Increase Diabetes Screening Eligibility

Learn more -> https://www.empr.com/home/news/using-new-guidelines-would-increase-diabetes-screening-eligibility/

Using New Guidelines Would Increase Diabetes Screening Eligibility Screening eligibility would increase overall and among those with prediabetes with USPSTF 2021, ADA 2022 guidelines

Hospital Outcomes Worse With Suboptimal Treatment of Hypothyroidism

Learn more -> https://www.empr.com/home/news/hospital-outcomes-worse-with-suboptimal-treatment-of-hypothyroidism/

USPSTF Advises Ag*inst Hormone Therapy to Prevent Chronic Conditions

Learn more -> https://www.empr.com/home/news/uspstf-advises-ag*inst-hormone-therapy-to-prevent-chronic-conditions/

USPSTF Advises Ag*inst Hormone Therapy to Prevent Chronic Conditions USPSTF recommends ag*inst hormone therapy for primary prevention of chronic conditions in postmenopausal persons

USPSTF Recommends Anxiety, Depression Screening for Children

Learn more -> https://www.empr.com/home/news/uspstf-recommends-anxiety-depression-screening-for-children/

Risk for Acute MI Not Increased With 2-Dose HepB-CpG Vaccine

Learn more -> https://www.empr.com/home/news/risk-for-acute-mi-not-increased-with-2-dose-hepb-cpg-vaccine/

Fintepla Approved for Lennox-Gastaut Syndrome

Learn more -> https://www.empr.com/home/news/fintepla-approved-for-lennox-gastaut-syndrome/

Accuretic, Authorized Generics Recalled Due to Nitrosamine Impurity

Learn more -> https://www.empr.com/home/news/safety-alerts-and-recalls/accuretic-authorized-generics-recalled-due-to-nitrosamine-impurity/

Accuretic, Authorized Generics Recalled Due to Nitrosamine Impurity Long-term use of products containing nitrosamine impurities may be associated with an increased cancer risk.

FDA Recommendations for Current Shortage of Prefilled Saline Flush Syringes

Learn more -> https://www.empr.com/home/news/safety-alerts-and-recalls/fda-recommendations-for-current-shortage-of-prefilled-saline-flush-syringes/

HPV Vaccination May Be Cutting Cervical Cancer Rates

Learn more -> https://www.empr.com/home/news/hpv-vaccination-may-be-cutting-cervical-cancer-rates/

Depression and Dry Eye Correlation Probed
'If the patient sees a doctor for dry eye, the doctor should check with the patient to see if they have depression. And if the patient has symptoms of depression, the doctor should check for dry eye.'

Learn more -> https://www.medscape.com/viewarticle/970394

Vonjo Approved for Myelofibrosis With Severe Thrombocytopenia

Learn more -> https://www.empr.com/home/news/vonjo-approved-for-myelofibrosis-with-severe-thrombocytopenia/

Breast Cancer Therapy-Related Cardiac Dysfunction Likely Diagnosed More Accurately With Combined Testing
In women with HER2-positive breast cancer, combined sequential use of echocardiographic 3-D LVEF with 2-D GLS and GCS provided a more timely and accurate diagnosis of cancer therapy-related cardiac dysfunction than when these measures were used individually.

Learn more -> https://www.medscape.com/viewarticle/968749

Pharmacotherapies for First-Line Treatment of mCSPC Explored

Learn more -> https://www.empr.com/home/mpr-first-report/asco-gu-2022/pharmacotherapies-for-first-line-treatment-of-mcspc-explored/